To investigate the effect of curcumin on visfatin and zinc-α2-glycoprotein (ZAG) expression levels in rats with nonalcoholic fatty liver disease (NAFLD).
Introduction
Non-alcoholic fatty liver disease (NAFLD) is a group of clinical pathological syndromes, and its disease spectrum includes simple fatty liver disease, non-alcoholic steatohepatitis, and related cirrhosis [1] [2] [3] [4] [5] . The pathogenesis of NAFLD is not yet clear but Day's "two-strike" theory is accepted by most scholars.
The role of visceral fat and associated visfatin in the pathogenesis of NAFLD is still controversial, and may cause liver cell steatosis and promote the occurrence of NAFLD. Zinc-α2-glycoprotein (ZAG) can regulate the activity of lipid metabolic enzymes, and hence maintain the balance of lipid metabolism to play a protective role in the pathogenesis of NAFLD [6] [7] [8] .
So far, there is no satisfactory treatment for NAFLD, and comprehensive therapies are usually performed in clinics. There are efficacy and safety concerns regarding a variety of drugs intended for the treatment of NAFLD. Recent studies have shown that curcumin has many effects such as antioxidant and anti-inflammatory effects, and oxygen free radical-scavenging effect.
Curcumin is the main active ingredient in turmeric
9
, and research has shown that it has some therapeutic effect on NAFLD 10, 11 . However, the specific mechanism is unclear.
Methods

Animals and establishment of NAFLD model
This study was carried out in strict accordance with the 12 h of light and dark, and all the rats were free to eat and drink.
They were randomly divided into the control group (16 rats) and the model group (40 rats), and were fed with a normal diet or high-fat diet (82.5% normal diet + 10% lard + 2% cholesterol (Lanji Technology Development Co., Ltd., Shanghai, China) + 0.5% sodium cholate (Lanji Technology Development Co., Ltd., Shanghai, China) + 5% sucrose), respectively. Rats in both groups were sacrificed at the end of the 8 th week, and their livers were taken for pathological examination, in order to confirm that the NAFLD rat model was successfully established.
Drug intervention
At the end of the 8 th week, rats in the model group were randomly divided into groups that received low (50 mg/kg/d), me- Table 1 .
TABLE 1 -Primer sequences of RT-PCR.
Gene
Upstream of primer Downstream of primer
Statistical analysis
SPSS19.0 software was used to analyze data, and the experimental data were expressed by x ±s. One-way ANOVA was used in the comparison between groups, and P < 0.05 was considered statistically significant.
Results
General observations
The rats in the control group were in good mental state, agile, and active. Their fur was bright, and their weight gradually increased on a normal diet. However, in the model group, rats were lazy to move and inactive, their fur was less shiny, and early weight gained on their diet decreased slightly. The state of the intervention group was between that of the control and model group.
Liver index of the rats
The liver index of rats in the model group was significantly increased compared with the control group (P < 0.01), and the liver index increased (P < 0.05) with increase in time. Curcumin administered at low, medium, and high dose could reduce the liver index in rats (treated groups compared to the model group, P < 0.01). The liver index decreased with increasing concentration of curcumin, but there was no significant difference between the groups with high dose (P > 0.05), and the liver index was not reduced to normal with curcumin intervention (P < 0.05).
Liver function of the rats
The serum ALT and AST of the model group increased as compared to the control group (P < 0.01), and continued to increase as time passed (P < 0.05). Curcumin could decrease serum ALT and AST levels in the rats (compared with the model group, P < 0.01). Furthermore, AST and ALT levels decreased with increasing concentration of curcumin and were significantly different between the groups with low, medium, and high dose (P < 0.05). However, the serum levels of ALT and AST did not decrease to normal with curcumin intervention (P < 0.05).
Blood lipid of the rats
The levels of TC and TG in the model group were significantly higher than the control group (P < 0.01) and they increased (P < 0.05) with passing time. Curcumin could decrease serum TC and TG levels in treated rats (compared with the model group, P < 0.05), and the effect was dose dependent. Serum TC levels was significantly different between treated groups (P <
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Fasting blood-glucose (FBG), fasting insulin (FINS), and the insulin resistance index (HOMA-IR) of the rats
The FBG, FINS, and HOMA-IR of rats in the model group were increased compared to the control group (P < 0.01) during the same period. The levels of serum FBG, FINS, and HOMA-IR increased with increase in time (P < 0.05). Curcumin could reduce HOMA-IR, FINS, and FBG serum levels in treated rats (P < 0.05), and this effect was dose dependent. HOMA-IR was significantly different between groups with low, medium, and high dose (P < 0.05). However, there was no significant difference between groups with low and medium dose for FBG (P > 0.05) and between groups with medium and high dose for FINS (P > 0.05). The levels of FBG, FINS, and HOMA-IR in the serum were not restored to normal levels with the curcumin intervention (P < 0.05).
Liver pathology of the rats
The examination of the control rats' livers showed that structure of hepatic lobule was intact, hepatic cord was radial, and 
Visfatin and ZAG protein expression in rat livers by immunohistochemistry
Compared with the control group, visfatin level increased (P < 0.01) but ZAG level decreased in the model group (P < 0.01). This trend was maintained with increasing time (P < 0.01). Curcumin could reduce visfatin levels and increase ZAG levels in liver tissue of rats (compared with the model group, P < 0.01), and the effect was dose dependent. Visfatin and ZAG levels in liver tissue were significantly different between groups treated with low, medium, and high dose (P < 0.01). Curcumin intervention did not restore either visfatin or ZAG levels to normal (P < 0.05). The control group was similar to the model group ( 
Visfatin mRNA expression in rat livers by semi quantitative RT-PCR
In the model group, the level of visfatin mRNA was significantly higher than the control group at the same time (P < 0.01). Visfatin mRNA level increased with time while establishing the model (P < 0.01). Curcumin could reduce visfatin mRNA levels in liver tissue of rats (P < 0.01), and the effect was dose dependent. There was significant difference between groups treated with low, medium, and high dose (P < 0.05), but the visfatin mRNA level in liver tissues was not restored to normal with the curcumin intervention (P < 0.05). The control group was similar to the model group (Table 3, Figure 4 ). The low dose group at 12th week; 6: The medium dose group at 12th week; 7: The high dose group at 12th week.
Discussion
Fukuhara et al. 14 . Vera-Ramirez et al. 38 found that curcumin had a vital effect on NF-κβ in the treatment of NAFLD. Nabavi et al. 39 suggested that curcumin could significantly decrease the serum parameters of non-alcoholic fatty liver, and its mechanism was related to the regulation of mitochondrial function and the maintenance of normal structure of liver cells.
In this study, we showed that the expression of visfatin protein increased and that of ZAG decreased in NAFLD rats.
The change in expression of ZAG and visfatin in liver tissue of the rats induced NAFLD. Therefore, is the expression of visfatin and ZAG protein a new mechanism of NAFLD, and can curcumin inhibit visfatin expression and induce ZAG expression in liver tissue for the treatment of NAFLD? Although the effect of curcumin as an anti-inflammatory and anti-oxidant has been proved, further studies on the prevention and treatment of NASH were still needed. In this study, curcumin treatment was used for NAFLD rats fed on a high fat diet for 4 weeks, and it was found that it could significantly improve liver function, relieve hepatic steatosis and inflammation, thereby proving the therapeutic effect of curcumin on NAFLD. Palma et al. 40 found that curcumin can promote differentiation of preadipocytes and reduce visfatin and resistin mRNA expression. This study showed that curcumin could improve IR, and significantly reduce levels of serum TG, TC. It could also increase ZAG expression and reduce visfatin activity as observed by the significant decrease in levels of serum ALT and AST, and improvement of liver histopathology.
In this study, liver fat changes were observed in the 8 In this study, we did not measure TNF-α and IL-6 levels, which was a limitation of the study.
Conclusion
Visfatin and zinc-α2-glycoprotein may be involved in the pathogenesis of NAFLD. Treatment of NAFLD in rats by curcumin may be mediated by the decrease of visfatin and the increase of non-alcoholic fatty liver disease.
